159 related articles for article (PubMed ID: 3291371)
21. Randomized trial of combination chemotherapy in hormone-resistant metastatic prostate carcinoma.
Page JP; Levi JA; Woods RL; Tattersall MN; Fox RM; Coates AS
Cancer Treat Rep; 1985 Jan; 69(1):105-7. PubMed ID: 3881176
[TBL] [Abstract][Full Text] [Related]
22. Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.
Calabresi F; Di Lauro L; Marolla P; Curcio CG; Paoletti G; Calabró A; Giannarelli D; Ballatore P; Foggi CM; Di Palma M
Semin Oncol; 1991 Apr; 18(2 Suppl 4):66-72. PubMed ID: 2031201
[TBL] [Abstract][Full Text] [Related]
23. [Controlled prospective study of chemotherapy in advanced ovarian cancer--cyclophosphamide monochemotherapy versus polychemotherapy with adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate].
Chylak V; Kolarić K; Krusić J
Lijec Vjesn; 1987 Jun; 109(6):230-4. PubMed ID: 3309515
[No Abstract] [Full Text] [Related]
24. Adriamycin and cyclophosphamide versus hydroxyurea in advanced prostatic cancer. A randomized Southwest Oncology Group study.
Stephens RL; Vaughn C; Lane M; Costanzi J; O'Bryan R; Balcerzak SP; Levin H; Frank J; Coltman CA
Cancer; 1984 Feb; 53(3):406-10. PubMed ID: 6362815
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer. A prospective randomized study.
Cocconi G; De Lisi V; Boni C; Mori P; Malacarne P; Amadori D; Giovanelli E
Cancer; 1983 Feb; 51(4):581-8. PubMed ID: 6336981
[TBL] [Abstract][Full Text] [Related]
26. Orchiectomy and chemotherapy with estramustine, cis-platinum, cyclophosphamide, and 5-fluorouracil in newly diagnosed prostate cancer with bone metastases.
Eisenkraft S; Huben RP; Pontes JE
Urology; 1984 Jun; 23(6 Suppl):51-3. PubMed ID: 6539524
[No Abstract] [Full Text] [Related]
27. Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome.
Manni A; Bartholomew M; Caplan R; Boucher A; Santen R; Lipton A; Harvey H; Simmonds M; White-Hershey D; Gordon R
J Clin Oncol; 1988 Sep; 6(9):1456-66. PubMed ID: 3047336
[TBL] [Abstract][Full Text] [Related]
28. Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a Western Cancer Study Group trial.
Irwin LE; Chlebowski RT; Weiner JM; Reynolds R; Pugh RP; Ryden VM; Bateman JR
Cancer Treat Rep; 1980; 64(8-9):981-4. PubMed ID: 7004635
[TBL] [Abstract][Full Text] [Related]
29. The chemotherapy of prostatic adenocarcinoma.
Torti FM; Carter SK
Ann Intern Med; 1980 May; 92(5):681-9. PubMed ID: 6992675
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP).
Carmo-Pereira J; Costa FO; Henriques E
Cancer; 1981 Oct; 48(7):1517-21. PubMed ID: 7026020
[TBL] [Abstract][Full Text] [Related]
31. A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.
Smalley RV; Bartolucci AA; Hemstreet G; Hester M
J Urol; 1981 Feb; 125(2):191-5. PubMed ID: 7206052
[TBL] [Abstract][Full Text] [Related]
32. [Results of the 1st Austrian ovarian cancer study: prospective randomized comparison of a new sequential chemotherapy with 2 standard regimens in 150 stage III and IV patients].
Sevelda P; Salzer H; Gitsch E; Karrer K
Onkologie; 1985 Dec; 8(6):388-91. PubMed ID: 3912695
[TBL] [Abstract][Full Text] [Related]
33. Polychemotherapeutic treatment for ovarian carcinoma (our experience).
Montoneri C; Garozzo G; Granà G; Castro R; Panella M; Granata D; La Greca M
Eur J Gynaecol Oncol; 1985; 6(2):160-3. PubMed ID: 4040858
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of hormone therapy alone and in combination with chemotherapy of cisplatin and methotrexate in newly diagnosed patients with stage D2 prostatic cancer].
Komatus H; Maesawa H; Tanabe N; Tago K; Ueno A
Nihon Hinyokika Gakkai Zasshi; 1996 Apr; 87(4):789-96. PubMed ID: 8691702
[TBL] [Abstract][Full Text] [Related]
35. Prostatic tumor acid phosphatase production. Influence of antineoplastic agents.
Li MC; Kanwal G; Kim RH
Urology; 1973 Mar; 1(3):221-5. PubMed ID: 4276286
[No Abstract] [Full Text] [Related]
36. [Combination chemotherapy with ifosfamide (or cyclophosphamide), adriamycin, cis-platinum and peplomycin (IAPP) for hormonally resistant metastatic prostatic cancer].
Maeda O; Saiki S; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
Hinyokika Kiyo; 1991 Dec; 37(12):1657-62. PubMed ID: 1723841
[TBL] [Abstract][Full Text] [Related]
37. Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group project.
Vogel CL; Smalley RV; Raney M; Krauss S; Carpenter J; Velez-Garcia E; Fishkin E; Raab S; Moore MR; Stagg M
J Clin Oncol; 1984 Jun; 2(6):643-51. PubMed ID: 6374057
[TBL] [Abstract][Full Text] [Related]
38. A randomized study of doxorubicin versus doxorubicin plus cisplatin in endocrine-unresponsive metastatic prostatic carcinoma.
Torti FM; Shortliffe LD; Carter SK; Hannigan JF; Aston D; Lum BL; Williams RD; Spaulding JT; Freiha FS
Cancer; 1985 Dec; 56(11):2580-6. PubMed ID: 4052935
[TBL] [Abstract][Full Text] [Related]
39. Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trial.
Muss HB; Howard V; Richards F; White DR; Jackson DV; Cooper MR; Stuart JJ; Resnick MI; Brodkin R; Spurr CL
Cancer; 1981 Apr; 47(8):1949-53. PubMed ID: 7194733
[TBL] [Abstract][Full Text] [Related]
40. A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer.
Silvey L; Carpenter JT; Wheeler RH; Lee J; Conolley C
J Clin Oncol; 1988 Sep; 6(9):1397-400. PubMed ID: 3047334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
